Literature DB >> 13845309

An unusual strain of Pasteurella pestis isolated from a fatal human case of plague.

C C WINTER, W B CHERRY, M D MOODY.   

Abstract

Entities:  

Keywords:  PASTEURELLA PESTIS

Mesh：

Year:  1960        PMID： 13845309      PMCID： PMC2555592     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  2 in total

1.  The effects of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis.

Authors:  T W BURROWS; G A BACON
Journal:  Br J Exp Pathol       Date:  1958-06

2.  Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis.

Authors:  E E BAKER; H SOMMER; L E FOSTER; E MEYER; K F MEYER
Journal:  J Immunol       Date:  1952-02       Impact factor: 5.422
  2 in total
  50 in total

1.  Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.

Authors:  Alexander V Philipovskiy; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

2.  A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Xinghong Yang; Sarah Golden; Catharine M Bosio; Kathryn Crist; Todd Becker; Massimo Maddaloni; David W Pascual
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

Review 3.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

4.  LcrV plague vaccine with altered immunomodulatory properties.

Authors:  Katie A Overheim; R William Depaolo; Kristin L Debord; Elizabeth M Morrin; Debra M Anderson; Nathaniel M Green; Robert R Brubaker; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Influence of Na(+), dicarboxylic amino acids, and pH in modulating the low-calcium response of Yersinia pestis.

Authors:  Robert R Brubaker
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  A monoclonal antibody for the specific diagnosis of plague.

Authors:  J E Williams; M K Gentry; C A Braden; G L Tyndal; P L Altieri; S Berman; D M Robinson
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

7.  Yersinia pestis IS1541 transposition provides for escape from plague immunity.

Authors:  Claire A Cornelius; Lauriane E Quenee; Derek Elli; Nancy A Ciletti; Olaf Schneewind
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

Review 8.  Intraspecific diversity of Yersinia pestis.

Authors:  Andrey P Anisimov; Luther E Lindler; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Richard Bowen; Xinghong Yang; Kathryn Crist; Sarah Golden; Massimo Maddaloni; David W Pascual
Journal:  Vaccine       Date:  2008-10-26       Impact factor: 3.641

10.  Specific identification of fraction I-positive Pasteurella pestis colonies on antiserum-agar plates.

Authors:  J M Albizo; M J Surgalla
Journal:  Appl Microbiol       Date:  1968-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.